Nextech Invest's Stella Paffenholz on finding opportunities during difficult markets
Stella Paffenholz says areas like gene editing, radiopharmaceuticals, and innovative small molecules make this an exciting time of innovation in biotech.
Also look for unique social pages for BiotechTV U.
#1. Pfizer’s CEO on Q2 earnings.
​
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
​
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
​
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square